Clinical decisions by the molecular tumor board on comprehensive genomic profiling tests in Japan: A retrospective observational study

Clinical decisions by the molecular tumor board on comprehensive genomic profiling tests in Japan: A retrospective observational study

Abstract Background A paradigm shift has occurred in cancer chemotherapy from tumor‐specific treatment with cytotoxic agents to personalized medicine with molecular‐targeted drugs. Thus, it is essential to identify genomic alterations and molecular features to recommend effective targeted molecular...

Full description

Bibliographic Details
Main Authors: Hidekazu Shirota, Keigo Komine, Masanobu Takahashi, Shin Takahashi, Eisaku Miyauchi, Hidetaka Niizuma, Hiroshi Tada, Muneaki Shimada, Tetsuya Niihori, Yoko Aoki, Ikuko Sugiyama, Maako Kawamura, Jun Yasuda, Shuhei Suzuki, Takeshi Iwaya, Motonobu Saito, Tsuyoshi Saito, Hiroyuki Shibata, Toru Furukawa, Chikashi Ishioka
Format: Article
Language:English
Published: Wiley 2023-03-01
Series:Cancer Medicine
Subjects:
C‐CAT
comprehensive genomic profiling
molecular tumor Board
personalized medicine
solid cancer
Online Access:https://doi.org/10.1002/cam4.5349

Internet

https://doi.org/10.1002/cam4.5349

Similar Items